Juvenile Myoclonic Epilepsy
RareNeurological
Juvenile Myoclonic Epilepsy is treated with 1 medication in our database, including Zonisamide. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by Concordia International. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Juvenile Myoclonic Epilepsy treatment below.
What help exists for Juvenile Myoclonic Epilepsy
6
drugs indexed
5
with copay cards
5
with patient assistance
0
open travel grants
Every item below links to the manufacturer's or charity's own portal. RxCopays does not take referral fees.
Drugs used to treat Juvenile Myoclonic Epilepsy
6 totalZonisamide
Zonisamide · Concordia International
🎟💙Levetiracetam Levetiracetam
Levetiracetam · UCB
🎟💙Keppra
levetiracetam · UCB
Spritam
levetiracetam · Aprecia
🎟💙LEVETIRACETAM
Levetiracetam · UCB
🎟💙LEVETIRACETAM solution
Levetiracetam · UCB
🎟💙
🎟 = copay card · 💙 = patient assistance program
Prior authorization patterns for Juvenile Myoclonic Epilepsy drugs
Aggregated from CMS SPUF + commercial PBM formularies. Specific rules vary by plan; confirm with your insurer.
| Payer | PA | Step therapy | Copay tier |
|---|---|---|---|
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
— Medicare Part D | — | — | — |
Juvenile Myoclonic Epilepsy is a rare disease — more resources at UniteRare
Our sister site covers specialists, clinical trials, patient communities, and rare-disease-specific diagnosis tools.
Visit UniteRare →